Neuro-2a drug treatment iTRAQ - A Bivalent Securinine Compound SN3-L6 Induces Neuronal Differentiation via Translational Upregulation of Neurogenic Transcription Factors

ABSTRACT: This project studies a compound, which induces potent neuronal differentiation, by using iTRAQ-based proteomic analysis in Neuro-2a progenitor cells.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Cell Culture

SUBMITTER: Yumei Liao  

LAB HEAD: Lei Shi

PROVIDER: PXD009180 | Pride | 2018-10-19

REPOSITORIES: Pride